Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint Inhibition.
- DOI
- 10.2147/jhc.s553808
- Published
- 2025
- Container
- Journal of hepatocellular carcinoma
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/jhc.s553808,
title = {Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint Inhibition.},
author = {Lüdemann WM and Kahn J and Herzler P and Collettini F and Savic LJ and Mohr R and Fehrenbach U and Auer TA and Gebauer B and Amthauer H and Wieners G},
year = {2025},
journal = {Journal of hepatocellular carcinoma},
doi = {10.2147/jhc.s553808},
url = {https://doi.org/10.2147/jhc.s553808}
}RIS
TY - JOUR TI - Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint Inhibition. AU - Lüdemann WM AU - Kahn J AU - Herzler P AU - Collettini F AU - Savic LJ AU - Mohr R AU - Fehrenbach U AU - Auer TA AU - Gebauer B AU - Amthauer H AU - Wieners G PY - 2025 JO - Journal of hepatocellular carcinoma DO - 10.2147/jhc.s553808 UR - https://doi.org/10.2147/jhc.s553808 ER -
APA
WM, L., J, K., P, H., F, C., LJ, S., R, M., U, F., TA, A., B, G., H, A., & G, W. (2025). Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint Inhibition.. Journal of hepatocellular carcinoma. https://doi.org/10.2147/jhc.s553808
Source records
- pubmed · retrieved 2026-09-26T11:19:54.368Z
- europe-pmc · retrieved 2026-09-26T11:19:54.388Z